Bal Pharma share news, announcements and annual reports
NSE: BALPHARMABSE: 524824Pharmaceuticals & BiotechnologySmall Cap
Bal Pharma Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1995 on BSE, May 2006 on NSE
Last close ₹84.61down ₹1.56 (1.81%)BSE ₹84.35
Share price at the NSE close on 29 Oct 2026. Previous close ₹86.17.
29 Oct: open ₹86.50, high ₹86.89, low ₹84.12
52-week range of traded prices to 29 Oct 2026
₹60.00Low, 30 Mar 2026₹124.60High, 10 Sep 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹135 Cr2,779th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 18.69
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.64
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.42%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 9.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.94
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,181
Bal Pharma shareholder meetings
60 filed, newest first. Page 2 of 2.
Aug 2010
23 Aug · Meeting
Annual General Meeting of the members of the Company will be held on September 27, 2010. Further the Register of Members and the Share Transfer Books will remain closed on September 27, 2010 for the purpose of the ensuing Annual General Meeting of the Company.
Dec 2009
15 Dec · Meeting
Minutes of the Annual General Meeting of the Company held on September 25, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2009
25 Sep · Meeting
Outcome of Annual General Meeting held on September 25, 2009 : 1) The audited Balance Sheet as at March 31, 2009 and Profit and Loss Account for the year ended on that date, together with the Directors' Report and Auditor's Report was adopted; 2) Dividend @ 7.5% was declared. 3) Dr. S. Prasanna was reappointed as Director. 4) Mr. Arun Bhan was reappointed as Director. 5) Messrs Ostawal & Jain, Auditors of the Company was reappointed and was authorized the Board of Directors to fix their remuneration. 6) Special resolution for appointment and increase in remuneration to Mr. Shailesh Siroya, Managing Director of the Company was approved by the Shareholders.
Jul 2009
28 Jul · Meeting
Register of members & share transfer books of the Company will remain closed from September 22, 2009 to September 25, 2009 (both days inclusive) for the purpose of payment of Dividend for the financial year, 2008-09. The said payment of dividend is subject to the approval of shareholders of the Company at the ensuing Annual General Meeting (AGM) of the Company to be held on September 25, 2009.
Sep 2008
26 Sep · Meeting
Minutes of the Annual General Meeting of the members of the Company held on September 23, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Sep · Meeting
Outcome of the Annual General Meeting of the company held on September 23, 2008. The details of the business transacted at the AGM shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2008
12 Aug · Meeting
Register of members and Share Transfer Books of the Company will remain closed from September 11, 2008 to September 23, 2008 (both days inclusive) for the purpose of payment of Dividend for the financial year, 2007-08. The said payment of dividend is subject to the approval of shareholders of the Company at the Annual General Meeting of the Company to be held on September 23, 2008.
Oct 2007
8 Oct · Meeting
Proceedings of Annual General Meeting of the Company held on September 20, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2007
24 Sep · Meeting
Annual General Meeting of the Company was held on September 20, 2007 as scheduled. Resolutions approving the followings were passed at the meeting. (1) Dividend @ 7.5% was declared. (2) Mr. Arun Bhan was reappointed as Director. (3) Dr. S Prasanna was reappointed as Director. (4) M/s Ostawal & Jain , Auditors of the Company was reappointed and was authorized the Board of Directors to fix their remuneration. (5) The remuneration paid to Mr. A.R. Hegde, Ex-Director & Chief Operating Officer was approved.
Aug 2007
23 Aug · Meeting
The Register of Members & Share Transfer Books of the Company will remain closed from 11th September, 2007 to 20th September, 2007 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Members of the Company to be held on 20th September, 2007 and for declaration of dividend